Skip to main content
Ashesh Jani, MD, Radiation Oncology, Atlanta, GA

Ashesh B Jani MD


Professor, Radiation Oncology, Emory University School of Medicine

Join to View Full Profile
  • 1365 Clifton Rd NeSte A1300Atlanta, GA 30322

  • Phone+1 404-778-3827

Dr. Jani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Chicago/University of Illinois College of Medicine at Chicago
    University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1996 - 2000
  • Rush University Medical Center
    Rush University Medical CenterInternship, Internal Medicine, 1995 - 1996
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1995

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2000 - 2026
  • GA State Medical License
    GA State Medical License 2006 - 2025
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Analysis of Radiation Facility Volume and Survival in Men with Lymph Node–Positive Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy  
    Pretesh R Patel, Sheela Hanasoge, Vishal R Dhere, Karen D Godette, Ashesh B Jani, Bruce Hershatter, JAMA Network Open

Press Mentions

  • Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
    Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual MeetingJune 8th, 2021
  • Fluciclovine PET Tracer Improves Recurrent Prostate Cancer Treatment Planning
    Fluciclovine PET Tracer Improves Recurrent Prostate Cancer Treatment PlanningOctober 30th, 2020
  • Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Using Advanced Imaging of Prostate Cancer for Radiotherapy
    Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Using Advanced Imaging of Prostate Cancer for RadiotherapyMay 30th, 2019
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: